Over the past 12 months, 2 insiders at IDEAYA Biosciences, Inc. filed 2 open-market SEC Form 4 transactions on IDYA: 1 purchase worth $1.6M and 1 sale worth $382K. Insiders have been mixed over this period. The most recent filing was on Jul 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | Briseno Andres RuizChief Accounting Officer | SELL | 9.6K | $40.01 | $382K |
| Mar 2, 26 | Jeffrey SteinDirector | BUY | 50.0K | $32.96 | $1.6M |
| May 29, 24 | Michael Anthony WhiteChief Scientific Officer | SELL | 27.6K | $36.78 | $1.0M |
| May 16, 24 | Yujiro S HataPresident and CEO | SELL | 30.1K | $42.37 | $1.3M |
| May 15, 24 | Yujiro S HataPresident and CEO | SELL | 53.6K | $44.12 | $2.3M |
| May 14, 24 | Yujiro S HataPresident and CEO | SELL | 54.4K | $41.84 | $2.3M |
| Feb 9, 24 | Briseno Andres RuizSee Remarks | SELL | 2.0K | $46.02 | $92K |
| Feb 9, 24 | Yujiro S HataPresident and CEO | SELL | 23.6K | $45.54 | $1.1M |
| Feb 8, 24 | Yujiro S HataPresident and CEO | SELL | 75.8K | $45.15 | $3.4M |
| Feb 1, 24 | Yujiro S HataPresident and CEO | SELL | 624 | $45.01 | $28K |
| Jan 22, 24 | Briseno Andres RuizSee Remarks | SELL | 2.0K | $42.03 | $84K |
| Jan 16, 24 | Yujiro S HataPresident and CEO | SELL | 62.7K | $40.17 | $2.5M |
| Jan 12, 24 | Yujiro S HataPresident and CEO | SELL | 12.3K | $40.04 | $491K |
| Jan 12, 24 | Briseno Andres RuizSee Remarks | SELL | 2.0K | $38.01 | $76K |
| Dec 15, 23 | Yujiro S HataPresident and CEO | SELL | 75.0K | $35.03 | $2.6M |
| Dec 15, 23 | Jason ThroneChief Legal Officer | SELL | 10.0K | $35.04 | $350K |
| Dec 14, 23 | Briseno Andres RuizSee Remarks | SELL | 1.7K | $34.01 | $57K |
| Nov 3, 23 | Jason ThroneChief Legal Officer | SELL | 5.2K | $30.09 | $155K |
| Sep 12, 23 | Jason ThroneChief Legal Officer | SELL | 500 | $30.01 | $15K |
| Sep 5, 23 | Jason ThroneChief Legal Officer | SELL | 1.7K | $30.03 | $52K |
| Sep 1, 23 | Briseno Andres RuizSee Remarks | SELL | 2.0K | $30.01 | $60K |
| Sep 1, 23 | Jason ThroneChief Legal Officer | SELL | 2.1K | $30.03 | $63K |
| Aug 29, 23 | Paul A. StoneChief Financial Officer | SELL | 5.0K | $28.87 | $144K |
| Aug 21, 23 | Paul A. StoneChief Financial Officer | SELL | 978 | $26.40 | $26K |
| Aug 18, 23 | Paul A. StoneChief Financial Officer | SELL | 3.8K | $26.38 | $101K |
| Aug 16, 23 | Paul A. StoneChief Financial Officer | SELL | 100 | $26.45 | $3K |
| Aug 9, 23 | Paul A. StoneChief Financial Officer | SELL | 2.5K | $25.05 | $63K |
| Aug 9, 23 | Jason ThroneChief Legal Officer | SELL | 5.0K | $25.09 | $125K |
| Jul 10, 23 | Jason ThroneChief Legal Officer | SELL | 9.5K | $23.00 | $218K |
| Jun 1, 23 | Jason ThroneChief Legal Officer | SELL | 3.6K | $23.02 | $82K |
| May 31, 23 | Jason ThroneChief Legal Officer | SELL | 432 | $23.00 | $10K |
| May 22, 23 | Jason ThroneChief Legal Officer | SELL | 500 | $23.00 | $12K |
| Oct 4, 21 | Michael P. DillonSVP, Chief Scientific Officer | SELL | 1.0K | $26.62 | $27K |
| Sep 8, 21 | Michael P. DillonSVP, Chief Scientific Officer | SELL | 11.2K | $27.67 | $307K |
| Sep 7, 21 | Michael P. DillonSVP, Chief Scientific Officer | SELL | 116 | $27.46 | $3K |
| Sep 7, 21 | Paul A. StoneSVP, Chief Financial Officer | SELL | 2.5K | $27.42 | $69K |
| Sep 2, 21 | Michael P. DillonSVP, Chief Scientific Officer | SELL | 10.0K | $25.09 | $251K |
| Aug 9, 21 | Michael P. DillonSVP, Chief Scientific Officer | SELL | 11.1K | $23.52 | $255K |
| Jul 27, 21 | Michael P. DillonSVP, Chief Scientific Officer | SELL | 10.0K | $25.15 | $252K |
| Jul 27, 21 | Jason ThroneSVP, General Counsel | SELL | 10.0K | $25.17 | $252K |
Over the past 12 months, insiders at IDEAYA Biosciences, Inc. filed 1 open-market purchase worth $1.6M and 1 sale worth $382K on IDYA, which makes them mixed over the period. The most recent Form 4 was filed on Jul 7, 26.
The largest recent open-market IDYA insider purchase in our data was $1.6M by Jeffrey Stein, Director, filed on Mar 2, 26.
2 different insiders at IDEAYA Biosciences, Inc. filed open-market SEC Form 4 transactions on IDYA over the last 12 months.
InsiderTape plots every IDYA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every IDEAYA Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →